Elevation Advisory Partners’s Johnson & Johnson JNJ Stock Holding History

Elevation Advisory Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,685	Closed	-$378K	–	68
2026 Q1	$378K	Buy	+1,685	New	+$392K	0.35%	50

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Elevation Advisory Partners's JNJ Position: Q2 2026 in Review

Elevation Advisory Partners sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 1,685 shares — an estimated $378K sold.

Elevation Advisory Partners first reported a position in JNJ in Q1 2026 and held it in 1 quarter. The position peaked at $378K in Q1 2026. 4,653 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Elevation Advisory Partners reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
Elevation Advisory Partners sold 1,685 Johnson & Johnson shares in Q2 2026, an estimated $378K.
Elevation Advisory Partners first reported a position in Johnson & Johnson in Q1 2026 and held it in 1 quarter.
Elevation Advisory Partners's Johnson & Johnson position peaked at $378K in Q1 2026.
4,653 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Elevation Advisory Partners's 13F filing for Q2 2026, filed 13 Aug 2026.